Search results
Added:
1 year ago
In this short interview Dr James V Freeman (Yale University School of Medicine, New Haven, CT, US) discusses the key findings from the study investigating in-hospital outcomes for Next-Generation Watchman FLX compared with Watchman Generation 2.5.
Discussion Points
Importance of this Study
Key Differences Between the Studied Devices
Study Design and Patient Baseline Characteristics
Key…
View more
New Insights in LAAC Imaging
Author(s):
Jens Erik Nielsen Kudsk
,
,
,
et al
Start date:
Dec 06, 2022
Broadcast
TCT 23: WATCH-TAVR
Author(s):
Samir R Kapadia
Added:
5 months ago
Video
Author(s):
Dhanunjaya Lakkireddy
Added:
1 year ago
TCT 2022 - Dr Dhanunjaya Lakkireddy (University of Kansas Hospital, Kansas City, US) joins us to discuss the safety and efficacy of the Amulet Left Atrial Appendage Occluder as suggested by the results of the AMULET-IDE Study.
AMULET-IDE was a prospective, multi-center study with a cohort of 1878 patients with non-valvular atrial fibrillation. Participants were randomized to receive either the…
View more
Author(s):
Sunil Kapur
,
Moussa Mansour
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting more than three million Americans.1 The management of AF revolves around the alleviation of symptoms related to an accelerated and irregular ventricular response, and the prevention of cardioembolism, notably stroke. In patients with AF, there is a fivefold increased incidence of embolic stroke.2 The prevention of systemic…
View more
Pugazhendhi Vijayaraman
Research Area(s) / Expertise:
Author
Added:
3 years ago
Dr Shephal Doshi (Pacific Heart Institute, Santa Monica, CA, US) discusses the results from the PINNACLE FLX Study.
The PINNACLE FLX Study is a prospective, non-randomized, multi-center investigation to establish the safety and effectiveness of the WATCHMAN FLX™ Left Atrial Appendage Closure Device for subjects with non-valvular atrial fibrillation who are eligible for long-term anti-coagulation…
View more
Author(s):
Wern Yew Ding
,
Dhiraj Gupta
Added:
3 years ago
AF is associated with an increased risk of thromboembolic events.1,2 Risk scores are used to identify patients at high risk of such complications who may benefit from anticoagulation therapy.3 However, despite a broad range of anticoagulant options and improved uptake in anticoagulation over the past decade, there are limitations to this approach. First, there is a significant proportion of high…
View more
ICE in LAAO
Author(s):
Juan Carlos Diaz
,
Mauricio Duque
,
Jorge Marin
,
et al
Added:
1 month ago
Article